Kallistatin protects against bleomycin-induced idiopathic pulmonary fibrosis by inhibiting angiogenesis and inflammation

Aberrant angiogenesis and vascular remodeling are the main features of idiopathic pulmonary fibrosis. Kallistatin is an anti-angiogenic peptide with known effects on endothelial cells. This study aimed to demonstrate that kallistatin has beneficial effects on bleomycin (BLM)-induced pulmonary fibros...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Transl Res
Main Authors: Huang, Xiaoping, Wang, Xiao, Xie, Xiaolan, Zeng, Shulan, Li, Zhaofa, Xu, Xianxiang, Yang, Huiyong, Qiu, Fei, Lin, Junsheng, Diao, Yong
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5375993/
https://ncbi.nlm.nih.gov/pubmed/28386328
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados